Health care facilities that still use fixed endcap duodenoscopes, which are no longer marketed in the U.S., should complete their transition to newer models that have disposable components or are fully disposable, which emerging data suggest can lower infection risks, the Food and Drug Administration this week. FDA has cleared seven duodenoscopes with disposable components that facilitate reprocessing or are fully disposable, and some manufacturers are offering replacement programs to upgrade to a model with a disposable component at no cost, the agency notes.

Related News Articles

Headline
The Food and Drug Administration today issued an alert on a potentially high-risk issue with Calyxo CVAC Aspiration Systems. In patients who have thick fluid鈥
Headline
In this conversation, Carlos Roberts, M.D., urogynecologist, vice president and chief medical officer of the Women and Children service line at WellSpan Health鈥
Headline
In this 鈥淪afety Speaks鈥 conversation, CommonSpirit Health's Beth Miller, system director, patient safety-performance improvement, and Austin Peterson, system鈥
Headline
The Food and Drug Administration Feb. 23 withdrew approval of Pepaxto (melphalan flufenamide), a drug once used with dexamethasone to treat certain U.S.鈥
Headline
AHA today submitted comments on how the Agency for Healthcare Research and Quality can best support the field in advancing patient safety through an鈥
Headline
Abbott has recalled certain lots of its Dragonfly OpStar imaging catheter because a marker band may separate from the catheter and remain in the patient after鈥